APA (7th ed.) Citation

Xiaoyuan Huang, Ting Fan, Li Li, Xuanxuan Nian, Jiayou Zhang, Xuefen Gao, . . . Xiaoming Yang. (2022). Safety and immunogenicity of a quadrivalent, inactivated, split-virion influenza vaccine (IIV4-W) in healthy people aged 3-60 years: A phase III randomized clinical noninferiority trial. Taylor & Francis Group.

Chicago Style (17th ed.) Citation

Xiaoyuan Huang, et al. Safety and Immunogenicity of a Quadrivalent, Inactivated, Split-virion Influenza Vaccine (IIV4-W) in Healthy People Aged 3-60 Years: A Phase III Randomized Clinical Noninferiority Trial. Taylor & Francis Group, 2022.

MLA (9th ed.) Citation

Xiaoyuan Huang, et al. Safety and Immunogenicity of a Quadrivalent, Inactivated, Split-virion Influenza Vaccine (IIV4-W) in Healthy People Aged 3-60 Years: A Phase III Randomized Clinical Noninferiority Trial. Taylor & Francis Group, 2022.